RE:Don't forget "Right to Try"Sounds fine to me. I have a feeling Theralase will be half my portfolio come late February. Probably not wise, but I have never claimed to be wise. The recent Sherri talks was interesting. She is busy. But man would Ilike to hear them start talking about GBM. Patience is learned the hard way, I guess. An interesting 2022 to say the least.